“The chronic administration of three daily doses of triazolam produced a decrease in glycine levels in almost all brain regions studied, which might be a prerequisite for oncoming withdrawal syndrome.”
“The acute triazolam administration produced an increase in glycine levels in almost all brain areas studied.”